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3Consumption of certain substances during pregnancy can interfere with brain development, leading to deleterious
long-term neurological and cognitive impairments in offspring. To test whether modulators of adenosine receptors
affect neural development, we exposed mouse dams to a subtype-selective adenosine type 2A receptor (A2AR) an-
tagonist or to caffeine, a naturally occurring adenosine receptor antagonist, during pregnancy and lactation. We ob-
served delayedmigration and insertion of g-aminobutyric acid (GABA) neurons into the hippocampal circuitry during
the first postnatal week in offspring of dams treated with the A2AR antagonist or caffeine. This was associated with
increased neuronal network excitability and increased susceptibility to seizures in response to a seizure-inducing
agent. Adult offspring of mouse dams exposed to A2AR antagonists during pregnancy and lactation displayed loss
of hippocampal GABA neurons and some cognitive deficits. These results demonstrate that exposure to A2AR antago-
nists including caffeine during pregnancy and lactation in rodents may have adverse effects on the neural develop-






















Neural development is strongly influenced by external (for example,
environmental) factors including certain drugs (1). These drugs are
known to modify cell migration (2, 3) and synapse formation (4, 5), re-
sulting in improper wiring of neuronal circuits, ultimately leading to
behavioral modifications in offspring later in life (6). There have been
few studies about the effects on fetal neural development of other sub-
stances such as the naturally occurring adenosine receptor antagonist
caffeine, which is ubiquitously consumed in coffee and tea. Mild to
moderate caffeine consumption (<200 mg/day) by mothers during
pregnancy and lactation is not considered harmful to the fetus and ne-
onate from the perspective of miscarriage or risk of prematurity. This is
reflected in the current guidelines for caffeine consumption during
pregnancy by the American College of Obstetricians and Gynecologists
(7–9). Although caffeine can cross the placenta and blood-brain barrier
(7), its impact on fetal and early postnatal development remains in-
conclusive (10). Caffeine has several molecular targets. At high concen-
trations (millimolar range), caffeine can inhibit phosphodiesterases
resulting in mobilization of calcium stores or it may have a direct effect
on g-aminobutyric acid typeA (GABAA) receptors (11). Such high con-
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www.Scieners of mild to moderate amounts of caffeine (7). In the micromolar
range, a concentration regularly found in humans (7), caffeine acts as
an antagonist of adenosine receptors, which modify numerous intra-
cellular signaling pathways including cyclic adenosine monophosphate
(cAMP)–dependent signaling (12). We set out to investigate the effects
of caffeine consumption by pregnant rodent dams on brain develop-
ment in their offspring. Because caffeine absorption takes place in the
gastrointestinal tract (7), we used a protocol of oral caffeine administra-
tion in mouse dams throughout pregnancy and lactation. We investi-
gated the short-term (during the first postnatal week) and long-term
(during adulthood) consequences of exposure to caffeine or a subtype-
selective adenosine type 2A receptor (A2AR) antagonist during fetal
development in the dam’s offspring.RESULTS
General effects of caffeine treatment on female mouse
dams and their pups
To mimic a routine daily consumption in human subjects, we exposed
female mice to caffeine (0.3 g/liter) in their drinking water during preg-
nancy and lactation. This dose (0.3 g/liter) leads to a plasma concentra-
tion of caffeine in rat dams similar to that found in the blood of humans
drinking three to four cups of coffee per day (13) and to a plasma con-
centration of caffeine in postnatal day 7 (P7) rat pups similar to that
found in the umbilical cord of human neonates of moderate coffee-
drinking (up to three cups per day) mothers (14). We found a similar
concentration of caffeine in female mice that were exposed to caffeine
(0.3 g/liter) in their drinking water [caffeine (1.0 ± 0.7 mg/liter) in
serum]. Treated females (n = 7) adapted quickly to the addition of
caffeine to the drinking water and thus showed no difference in water
intake from 2 days after the start of caffeine treatment onward (fig. S1A).
Food intake of caffeine-treated and untreated female mice was similarceTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 1





























 (untreated, 3.48 ± 0.12 g/day; treated, 3.48 ± 0.13 g/day; P = 1.0). There
was no difference in weight increase throughout pregnancy between
control and caffeine-treated dams (fig. S1B).
Addition of caffeine to the drinking water led to enhanced activity
during the active (dark) period, but not during the sleep (light) period of
the day. The day-night cyclewas not affected by the treatment (fig. S1C).
During the first 2 weeks of life, the general condition of pups was qual-
itatively assessed during the dark period every second day. In both
caffeine-treated and control groups, all dams built a nest and pups were
in all cases found with the mother within the nest. The gestational pe-
riod of the control and caffeine-treated femaleswas similar (19 to 20 days),
and the litter sizes were not different between the two groups (fig. S1D).
Caffeine was present in the brain of pups, where it reached concentra-
tions of 1.06 ± 0.19 ng/mg together with its metabolic products,
namely, theobromine (0.62 ± 0.02 ng/mg) and 1,3-dimethyluric acid
(0.21 ± 0.04 ng/mg) (n = 5, P1 to P8 pups). Pups born from caffeine-
treated dams displayed a transient body weight reduction between P1
and P11 that was gender-independent and that was normalized at P24
(fig. S1E). The weight of 13-week-old adult offspring was not changed
by caffeine exposure (caffeine-treated group, 22.2 ± 3.5 g; control group,
24.2 ± 3.2 g; P = 0.22). Motor development and development of neuro-
logical reflexes during the first 11 days of life were not affected by caf-
feine exposure because the righting reflex (fig. S1F) and cliff avoidance
behavior (fig. S1G) were not significantly different between caffeine-
exposed and control offspring.
Together, these data indicate that caffeine treatment during preg-
nancy and lactation has a major influence neither on female mice nor
on pups’ sensorimotor development. We next assessed whether the
construction of neuronal networks was affected by caffeine treatment,
focusing on GABAergic circuits, which are often altered by various
types of insults.
Caffeine treatment of dams alters GABA neuron migration
in their offspring
Using GINmice [green fluorescent protein (GFP)–expressing inhibito-
ry neurons] that express GFP in a subpopulation of somatostatin-
containing GABA neurons (15, 16), we found a consistent decrease in
GFP-labeled neurons in the hippocampus and superficial cortical layers
of all caffeine-exposed offspring (n= 11 pups) compared to controls (n=
10 pups) at P6 (Fig. 1, A and B). There was a 41% (P < 0.05) decrease in
GABA neurons in the hippocampus of caffeine-exposed offspring at P6
(Fig. 1H andTable 1). In contrast, the distribution pattern (Fig. 1, D and
E) and estimated number (Fig. 1H and Table 1) of hippocampal GFP-
expressing neurons were similar in 3-month-old adult control and
caffeine-exposed offspring. We thus hypothesized that caffeine may
delay the migration of GABA neurons.
Cortical GABA neurons are generated within the ventral telencephalon
by the medial and caudal ganglionic eminences (MGE and CGE) in
mice (17–19); somatostatin-containing neurons are generated in the
MGE (20, 21). Cortical GABA neurons first migrate tangentially
before switching to a radial migration as they invade the cortical plate.
Many GABA neurons keep migrating postnatally to reach their target
layers (18, 22, 23). In keeping with this rule of migration, in control
GIN mice, some GFP-labeled neurons were observed in the deep
cortical layers at P1 (fig. S2, A and E), as they started their radial mi-
gration to the superficial layers. At P3, few GFP-labeled neurons were
positioned in the superficial supragranular layer (fig. S2, B and F) and
in the stratum oriens of the hippocampus (fig. S2I). At P6, many mor-www.Scienphologically differentiated GFP-labeled neurons were evident in the
superficial cortical layers (fig. S2, D and H) and in the hippocampus
(Fig. 1A and fig. S2K). The distribution patterns of GFP-labeled neu-
rons and axon terminals in caffeine-exposed offspring at P6 (fig. S2, C,
G, and J) were similar to that observed at P3 in control mice (fig. S2,
B, F, and I), supporting the hypothesis that caffeine delayed the mi-
gration and insertion of interneurons in cortical networks.
Caffeine treatment affected themigration of the entire population of
somatostatin-containingGABAneurons (fig. S3, A to F). Somatostatin-
containing neurons displayed an immature distribution pattern in
caffeine-exposed offspring at P6, illustrated by the presence of many
somatostatin-containingneurons, includingmigratingneurons in the stratum
radiatum (control, 25 neurons/mm2, n = 3 pups from three dams; caffeine-
exposed, 58 neurons/mm2, n = 3 pups from three dams) similar to that
observed at an earlier developmental stage in controlmice (fig. S3,A toF).
To assess the general state of the GABAergic circuitry, we investi-
gated the distribution pattern of the vesicular GABA transporter
(VGAT), which labels GABAergic terminals. VGAT labeling displayed
immature features in caffeine-exposed offspring at P6, namely, low con-
centrations of labeled terminals in the CA3-CA1 pyramidal cell (PC)
layer and high concentrations in dendritic layers, as found in control
P3 animals (fig. S3, G and H) (24). In contrast, control P6 mice
displayed a high concentration of terminal labeling in the PC layer typ-
ical of more mature networks (fig. S3I).
The delayed insertion of GABA neurons in cortical circuits suggests
that caffeine may interfere with processes that control GABA neuron
migration. This hypothesis was directly tested in vitro using time-lapse
video microscopy (Fig. 1I). In cocultures prepared at embryonic stage
13.5 (E13.5), GABAneurons from theMGEmigrate radially away from
their explants of origin on a substrate of dissociated cortical cells (25, 26).
Thirty to 45min after caffeine application, themeanmigration speed of
MGE neurons was decreased by 53% (P < 0.001, n = 46 of 52 cells), an
effect that persisted until the end of the recording session, up to 10 hours
in some experiments (Fig. 1, J and K). A small percentage of MGE cells
(11.5%, n = 6 of 52 cells) did not respond to caffeine application or re-
sponded by increasing their migration speed. We then investigated the
adenosine receptor subtype(s) involved in the control of GABA neuron
migration.
A2ARs may control the migration of GABA neurons
Chronic consumption of caffeine exerts its central action mostly via its
antagonistic action onA2ARs (27, 28).We thus substituted caffeine with
the selective A2AR antagonist KW6002 (istradefylline, 2mg/kg per day).
Exposure to KW6002 (Fig. 1, C, F, andH), but not to its vehicle solution
(Fig. 1G), reproduced the effects of caffeine, suggesting that caffeine
delayed GABA neuron migration via its antagonistic action on A2AR
(Table 1). Application of the selective A2AR antagonist SCH58261
(200 nM) to MGE neurons reproduced the effect of caffeine, reducing
the migration speed ofMGE cells by 56% (P < 0.001, n = 57 of 62 cells),
with a small percentage of cells (8%, n = 5 of 62) not responding to the
antagonist or increasing their migration speed (Fig. 1, I, L, and M). In
contrast, the A1 receptor antagonist DPCPX (200 nM) did not change
the migration speed of MGE cells (Fig. 1, N and O). In the absence of
drug, the migration speed of MGE neurons was not modified through-
out the recording period (Fig. 1P).
These results demonstrate that the endogenous activity of A2AR is
important for GABA neuron migration. We thus determined whether
A2ARs are indeed expressed bymigratingGABAneurons.Using immu-ceTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 2





























 nohistochemistry, we found A2AR in somatostatin-containing GABA
neurons, leaving the ganglionic eminence at E13 in rats, in particular
within the leading process, a key element of cell migration (29) (Fig. 2,
A to F). A similar scenario may be at play in primates as we also found
A2AR in tangentially and pseudo-radially migrating GABA neurons (30)
in macaque fetal brain at E75 (Fig. 2, G and H). The intracellular path-
ways linking A2AR activation and cell motility, as well as the source of
adenosine remain to be determined.www.ScienTo further confirm that caffeine interfereswithA2AR-dependentmi-
gration of somatostatin-containing GABA neurons, we performed caf-
feine and KW6002 treatments in mouse dams constitutively lacking
A2AR (A2AR-KO). All A2AR-KO pups showed a decreased number of
somatostatin-containing GABA neurons in both the hippocampus and
superficial cortical layers (fig. S4, A to F). Somatostatin-containing
neurons of A2AR-KO pups displayed poorly developed dendritic pro-
files compared to wild-type pups of the same strain (fig. S4, G and H),Fig. 1. Caffeine exposure during
the embryonic and early postnatal
period impairs the migration of
hippocampalGABAneuron subpop-
ulations in mouse brain. (A to F)
Representative coronal sections (6
to 10 examinedper animal) fromcon-
trol (A and D), caffeine-exposed (B
and E), and KW6002-exposed (C and
F) offspring of GIN mice at postnatal
day 6 (P6) (A to C) and at 3 months
(adult) (D to F). Photomicrographs
show the distribution pattern of GFP-
containing neurons (white arrowheads)
in the hippocampus (HP) and cortex
(CX). (A)ManyGFP-containingneurons
were already present in the superficial
layers of the cortex and hippocampus
in control pups. (B and C) Caffeine or
KW6002 exposure during gestation
resulted in a marked decrease in
GFP-labeled cell bodies (white arrow-
heads), axons, and dendrites in the
hippocampus and cortex at P6. In con-
trast, no major differences in GFP la-
beling of the hippocampus and cortex
were observed between control (D)
and caffeine-exposed (E) or KW6002-
exposed (F) adult offspring. (G) Expo-
sure to vehicle during gestation did
not modify the pattern of distribution
ofGFP-containingneurons in offspring.
(H) Estimated total number of GFP-
expressing neurons in the hippocam-
pus of caffeine-exposed (n = 3) or
KW6002-exposed (n = 2) P6 offspring
was smaller (P < 0.05) than in control
(n=4). In contrast, the estimatednum-
ber of GFP-containing neurons was
similar in the three adult groups (n =
3, 3, and 4, respectively; P = 0.508). (I)
Representative time-lapse video se-
quence illustrating a GFP-expressing
MGEmouseneuron(whitearrow)invitro
migrating on a substrate of disso-
ciated cortical cells in response to the application of SCH58261 [5-amino-7-
(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine]
(vertical black arrow) (time is in hours:minutes). (J toO) Caffeineor SCH58261,
but notDPCPX (8-cyclopentyl-1,3-dipropylxanthine), decreased themigration
speed of MGE cells in coculture. (J, L, and N) Bar graphs compare the mean
migration speed ofmore than 50MGE cells measured during a 2-hour period
before and after application of caffeine (J, n = 52), SCH58261 (L, n = 62),
or DPCPX (N, n = 83). P < 0.001 in (J) and (L), not significant in (N), Student’s
t test. (K, M, and O) Time course of instantaneous migration speed for repre-csentativeMGE cells exposed to caffeine (K), SCH58261 (M), or DPCPX (O). Ver-
tical black arrow indicates when the drug was applied. (P) In the absence of
drug, the mean migration speed of MGE cells did not change during the
recording period as demonstrated by the curves on the left, comparing
the time course of nuclear movements in two MGE cells recorded in two
contiguous cocultures: one without treatment (top) and one treated with
SCH58261 (bottom). Right: The decrease in the mean nuclear migration
speed was significant 1 hour after SCH58261 application (gray bars). *P <
0.05, **P < 0.01, ***P < 0.001. Scale bars, 250 mm (A to G) and 20 mm (I).eTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 3





























 suggesting that loss of A2ARs impairs the migration and insertion of
GABA neurons in cortical and hippocampal layers. Neither caffeine
norKW6002 treatment further decreased the number ofGABAneurons
in the hippocampus of A2AR-KO pups (fig. S4I), further supporting the
notion that the phenotypic traits found in caffeine or KW6002-treated
wild-type animals are due to a selective action of these drugs on A2ARs.
Abnormal GABA neuron migration may lead to altered network
function (31). We thus assessed whether exposing dams to caffeine
modified electrophysiological activity in the hippocampus of their
offspring.
The hippocampus is hyperexcitable in caffeine-treated
rodent offspring
During the first postnatal week, in vitro hippocampal activity is charac-
terized by the occurrence of giant depolarizing potentials (GDPs),which
constitute a good readout of network activity and excitability (32). The
frequency of GDPs in the hippocampal CA3 region was 217% higher in
caffeine-treated pups compared to controls and 206%higher in KW6002-
treated compared to vehicle-treated pups (Fig. 3, A and B, and table S1).
The properties of GDPs depend on the activation of glutamate and
GABAA receptors (32). Measuring both GABAergic and glutamatergic
synaptic inputs (drives) received by CA3 PCs during GDPs, we found a
74% increased contribution of the glutamatergic synaptic input to the
overall synaptic input (glutamate + GABA) (Fig. 3C and table S2) in
caffeine-exposed animals (n = 7 cells from five pups, four dams) com-
pared to controls (n = 6 cells from three pups, three dams) and a 130%
increase in KW6002-treated pups (n = 3 cells from three pups, three
dams) compared to vehicle-exposed pups (n = 5 cells from three
pups, two dams). In contrast, in stratum radiatum interneurons, the
glutamatergic synaptic input was similar in control (n = 10 cells from
three pups, two dams), vehicle-exposed (n = 6 cells from three pups,
two dams), caffeine-exposed (n = 15 cells from four pups, four dams),
and KW6002-exposed (n = 14 cells from four pups, four dams) ani-
mals (Fig. 3C and table S2).
In CA3 PCs, the frequency of spontaneous inhibitory postsynaptic
currents (sIPSCs) and spontaneous excitatory postsynaptic currents
(sEPSCs), which are measured between GDPs, was increased by 238
and 466%, respectively, in caffeine-exposed, and by 241 and 350%, re-
spectively, in KW6002-exposed pups (Fig. 3, D to G, and table S3). In
stratum radiatum interneurons, the frequency of sIPSCs and sEPSCs
was increased by 428 and 325%, respectively, in caffeine-exposed, and
by 407 and 245%, respectively, in KW6002-exposed animals (Fig. 3, D
to G, and table S3). The corresponding decrease in the mean interevent
interval (IEI), which is the time between two consecutive synaptic in-
puts, is displayed in the histograms below the frequency curves. The
contribution of the glutamatergic synaptic input carried by sEPSCs towww.Scienthe overall synaptic input in CA3 PCswas increased by 134% in caffeine-
exposed and 125% in KW6002-exposed pups (Fig. 3H and table S4).
However, it remained unchanged in stratum radiatum interneurons
(Fig. 3H and table S4) because both glutamatergic and GABAergic
drives were similarly increased in caffeine- or KW6002-exposed ani-
mals. There is thus a general increased synaptic (glutamatergic and
GABAergic) and network (GDP) activity in caffeine-exposed offspring
compared to controls. Although appearing counterintuitive given the
delayed insertion of GABA neurons, an increase in GABAergic activity
is consistently found in several pathological contexts. For example,mice
lacking lissencephaly-1 protein (33, 34) are characterized by defects in
GABA neuron migration (35), which are overcompensated for by hy-
peractivity of the remaining GABA neurons (33, 34).
Network hyperactivity can induce neuronal injury, in particular in
GABA neurons (36), and is typified by dendritic swellings. In keeping
with the increased network activity (GDPs, sEPSCs, and sIPSCs) re-
ceived by GABA neurons, we consistently found large varicosities (sug-
gesting swelling) along the dendrites of all GFP-expressing neurons in
GINmice (Fig. 3J) and recorded biocytin-filled interneurons (Fig. 3L) in
caffeine-exposed offspring at P6. These varicositieswere not observed in
interneurons in controls (Fig. 3, I and K) or in PCs from caffeine-
exposed offspring (Fig. 3M). Such selective effects on GABA neurons
may result in cell dysfunction, perhaps contributing to the shift in the
balance between excitatory and inhibitory inputs in principal cells.
We conclude that the anatomical alterations induced by caffeine (or
KW6002) exposure are paralleled by physiological modifications in the
developingbrain of offspring. Thehippocampal circuitry is characterized
by a general hyperactivity, as evidenced by an increase in the frequency
of GDPs, sEPSCs, and sIPSCs, as well as a shift in the balance between
the GABAergic and glutamatergic synaptic inputs in favor of the latter
in CA3 PCs.
Immature neuronal networks are seizure-prone (37), and defects in
GABA neuron migration or in GABAergic signaling during develop-
ment facilitate the emergence of an epileptic phenotype (31, 38). We
thus tested seizure sensitivity in caffeine-exposed offspring during the
first postnatal week.
Caffeine exposure increases susceptibility of mouse
pups to seizures
We used flurothyl, a seizure-inducing agent (39), to assess seizure sus-
ceptibility in caffeine-exposed and control offspring at P6. Pairs of
caffeine-exposed/control and KW6002-exposed/control pups at P6
were exposed to flurothyl in two independent sessions (four treated
and four control animals per session). None of the pups analyzed (eight
controls from two dams, four caffeine-exposed pups fromone dam, and
four KW6002-exposed pups from one dam) displayed seizures whenTable 1. Estimated number of GFP-containing neurons in control,
caffeine-exposed, and KW6002-exposed pup and adult offspring.
The number of GFP-containing neurons was decreased in the hippo-
campus of caffeine- and KW6002-exposed P6 offspring but not adultoffspring. Given that the morphological pattern of distribution, as well
as the immunoreactivity, in hippocampus from vehicle-exposed animals
was similar to controls, a stereological quantification was not performed
in the vehicle group.P6 control P6 caffeineceTranP6 KW6002slationalMedicine.Adult controlorg 7 August 201Adult caffeine3 Vol 5 Issue 197Adult vehicleExperimental number 4 pups, 3 dams 3 pups, 3 dams 2 pups, 3 dams 4 3 3Estimated number of GFP-containing neurons 4239 ± 398 2838 ± 317* 1971 ± 315*† 9336 ± 1173 8213 ± 1825 7152 ± 500*P < 0.05 versus control, one-way analysis of variance (ANOVA). †P < 0.05 versus caffeine, one-way ANOVA.197ra104 4












































.0.1ml of flurothyl was applied in the cage (Table 2). However, two pups
from each of the treated group (caffeine and KW6002) displayed aber-
rantmovements, whereas none of the control animals did.When 0.2ml
of flurothyl was applied in the cage, only 6 abnormal movements were
observed in the control group, whereas all treated pups made a total of
43 abnormal movements. At this flurothyl concentration, 100% of
treated pups displayed seizures versus 38% in the control group. The
time to trigger seizures, as well as the duration of seizures, was similar
in treated and nontreated offspring (Table 2).We conclude that animals
exposed to caffeine or KW6002 during the developmental period are
more susceptible to seizures than controls, in agreementwith the hyper-
excitability of hippocampal networks found in vitro.www.ScienInterfering with GABAergic circuits during development alters neu-
ronal networks in the adult at both structural and functional levels, and
leads to cognitive deficits (31, 40, 41). We thus analyzed whether caf-
feine or KW6002 exposure led to long-term sequelae in adult hippo-
campal networks and assessed possible functional consequences.
Hippocampal neuronal networks are altered in
adult rodent offspring
Using immunohistochemistry for the neuron-specific nuclear protein
(NeuN), we found a marked neuronal loss in the stratum oriens and
stratum radiatum/lacunosum moleculare of the CA1-CA3 region as
well as in the hilus of the dentate gyrus of caffeine-exposed (n = 7)Fig. 2. A2ARs are expressed by migrat-
ingGABAneurons in the rat andmonkey
fetal telencephalon. (A to C) Represent
ative adjacent coronal sections (of five to
six examined per animal) of the rat tel-
encephalon at E13. (A)Mostnewlygenerated
somatostatin-containingneurons (SOM;black
arrows) were located in the preplate (PP) o
the ventral telencephalon, at the level o
the ganglionic eminence (GE) with a few in
the preplate of the adjacent dorsal tel
encephalon (black arrowheads). (B) Immu
nolabeling of A2ARs was detected in these
same regions (arrows). (C) Cresyl violet–
stained section showing the ganglionic emi
nenceand theproliferative zone of the dorsa
telencephalon including the subventricular
(SVZ) and ventricular (VZ) zones. (D) Higher
magnification of a somatostatin-containing
neuron from (A) with a characteristic mor
phology of a migrating neuron including
a leading process (black arrows). (E) Accu
mulation of A2AR immunolabeling in the
cell body and leading process (black arrows
of a migrating somatostatin-containing
neuron. (F) Confocal image of a migrating
somatostatin-containing neuron in the
preplate (white asterisk, cell body; white
arrows, leading process). Cell is double
labeled for somatostatin (green) and A2AR
(red). (G and H) A2AR immunolabeling o
a representative coronal section of the
monkey fetal telencephalon at E75. (G
A2AR immunoreactivity was detected in
the lower intermediate zone (IZ)/upper
subventricular zone (arrowheads). (H) High
ermagnificationof the region in (G) showing
many tangentially oriented migrating
neuron-like cells immunolabeled for A2AR
(black arrows). Scale bars, 50 mm (A to C)
5 mm (D to F), 250 mm (G), and 25 mm (H)ceTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 5
































aand KW6002-exposed (n = 4) adult offspring (3months old) compared
to control (n = 12) mice (Fig. 4, A and B, and Table 3). The estimated





)decreased, respectively, by 38 and 19% in the stratum oriens, by 34 and
24% in stratum radiatum/lacunosummoleculare, and by 39 and 22% in
the hilus of the dentate gyrus (Fig. 4E and Table 3). Given that, in con-hich corresponds to a lower inhibitory
(D and E) Representative traces of sIPSCs
in a stratum radiatum interneuron and a




in P6 mouse offspring. (A)
Representativetracesofspon-
taneous activity recorded
at a holding potential of
+10 mV in a hippocampal
CA3 PC from a brain slice of a
controloracaffeine-exposed
pupatP6.Blackasterisks rep-
resent GDPs. Note the in-
crease in the frequency of
GDPs and of spontaneous
synaptic currents recorded
between GDPs in caffeine-
exposedoffspring. Inset: De-
tail of aGDPevent indicated
by#. (B) Bar graphs showing
a decreased mean IEI be-
tweenGDPs recorded inhip-
pocampal brain slices from
caffeine-exposed pups com-
pared to control pups (**P <
0.01) and from KW6002-
exposed pups compared to
vehicle (*P < 0.05). (C) The
glutamatergic contribution
to theoverall synaptic input
during GDPs was increased
in PCs (**P<0.01) but not in
the stratum radiatum (R)
interneurons (IN) (P = 0.82)




currents recorded at −60 and
+10 mV, respectively, dur-
ing GDPs in a CA3 PC and
a stratum radiatum inter-
neuron. The area under the
curve was smaller in GDPs
corded at +10 mV in PCs
f caffeine-exposed pups, w
harge transfer to the cells.
nd sEPSCs recorded in vitro
PC from control and caffeine
probability distributions of IEIs for sIPSCs and sEPSCs recorded in vitro in a stratum radiatum interneuron and a PC from control and caffeine-exposed
mouse offspring. Bar graphs showing themean IEI are displayed below the cumulative probability distributions. In hippocampal slices from caffeine- o
KW6002-exposed offspring, the IEI of sIPSCs (left panels) and sEPSCs (right panels) was decreased in stratum radiatum interneurons and in PCs com
pared to control or vehicle-exposed animals. (H) The contribution of the glutamatergic synaptic input to the overall synaptic input was increased
selectively in PCs from caffeine- and KW6002-exposed offspring, but this was not observed for stratum radiatum interneurons (PCs, *P < 0.01; inter
neurons, P = 0.23). (I and J) GFP-labeled neurons in a control (I) and in a caffeine-exposed (J) P6 pup (same as in Fig. 1). (K to M) Biocytin-labeled
interneurons (I and J) and PCs (K) recorded in vitro in a control (K) and a caffeine-exposed (L andM) P6 pup. In neurons from caffeine-exposed offspring
varicosities were consistently observed along dendrites of interneurons labeled with GFP (J, black arrows) or with biocytin (L, black arrows) but no
along dendrites of PCs (M). These varicosities on dendrites are reminiscent of swelling profiles observed after excitotoxic damage. Scale bars, 50 mm (I and J
and 25 mm (K to M).




3trol GINmice, 87%of the stratumoriens neurons contain somatostatin,
a population of neurons known to be particularly vulnerable in patho-
logical conditions (42–45), we specifically analyzed their fate in adult
caffeine-exposed offspring.Most of the cell loss observed in the stratum
oriens corresponded to a 30% decrease in somatostatin-containing
GABA neurons (Fig. 4, C, D, and F, and Table 3). The loss of somatostatin-
containing neurons was region-specific because no difference in the
number of somatostatin-containing neurons was found in the hilus of
the dentate gyrus between treated (Fig. 4, D and F, and Table 3) and
control mice (Fig. 4, C and F, and Table 3). The cell loss was also cell
type–specific, because the number of GFP-containing interneurons,
which represent a subpopulation of somatostatin-containing neurons
in GIN mice, was not modified in adult animals (Fig. 1).
We then investigated whether the loss of somatostatin-containing
interneurons in the stratum oriens was associated with electrophysio-
logical modifications in CA1 PCs, the main target of these neurons and
the output region of the hippocampal network. The frequency of sIPSCs
was increased by 155 and 252% in caffeine- andKW6002-exposed adult
offspring, respectively (Fig. 5, A and C, and table S5), whereas theTable 2. Seizure susceptibilityof control andcaffeine-orKW6002-exposed
pups to theconvulsingagent flurothyl.Caffeine-or KW6002-exposedP6pups
were more vulnerable to flurothyl than control pups of the same age (eight
controls from two dams, four caffeine-exposed pups from one dam, and four
KW6002-exposed pups from one dam). Treated pups displayed a higher
number of abnormal (spasm-like) movements after exposure to flurothyl,
and the proportion of treated pups thatmanifested clonic seizures at a lower
concentration of flurothyl (0.2 ml) was greater. No differences were found be-






























 Fig. 4. Caffeine treatment leads toGABAergic cell loss in adult offspring. (A
to D) Representative hippocampal coronal sections (of 10 to 12 examined per
KW6002-exposedoffspring showasignificantdecrease in thenumberof neurons
incaffeine-andKW6002-exposedadultoffspringcomparedtocontrol in thestratumanimal) from control (A and C) and KW6002-exposed (B and D) adult mouse off-
spring immunolabeled for NeuN (A and B) and somatostatin (C and D). (A and B)
NeuN-labeled cell bodies (arrowheads) were decreased in the stratum oriens (O)
and thehilus (H) of thedentategyrus in KW6002-exposedoffspring (B) compared
tocontrols (A). (D)KW6002-exposedoffspringshowedadecrease insomatostatin-
containing neurons (arrowheads) compared to control (C). (E) Bar graphs of the
estimated number of NeuN-containing neurons in control and caffeine- ororiens (caffeine, **P<0.01; KW6002, *P<0.05), radiatum/lacunosummoleculare
(R/LM) (caffeine, **P < 0.01; KW6002, *P < 0.05), and hilus (caffeine, **P < 0.01;
KW6002, *P < 0.05). (F) Bar graphs of the estimated number of somatostatin-
containingneuronsshowasignificantdecreaseinthenumberofneurons incaffeine-
andKW6002-exposedoffspringcomparedtocontrol in thestratumoriens (*P<0.05)
but not in thehilus (P=0.132). P, stratumpyramidale;M,molecular layer of theden-
tate gyrus; G, granular cell layer. *P<0.05, **P<0.01. Scale bars, 50 mm(A toD).ceTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 7






























 frequency of sEPSCswas decreased by 79 and 82% in adult caffeine- and
KW6002-exposed adult offspring, respectively (Fig. 5, B and D, and
table S5). The corresponding mean decrease in the IEI between consec-
utive synaptic events is displayed by the histograms below the frequency
curves. As a result, the contribution of the glutamatergic synaptic input
to the overall synaptic input was decreased by 48% in caffeine- and
KW6002-exposed compared to control and vehicle-treated animals
(Fig. 5E). Thismay reflect a reorganization of the hippocampal circuitry
in adult caffeine-exposed offspring, whichmay involve a hypoactivity of
glutamatergic networks as well as a hyperactivity of GABAergic net-
works (33, 34, 42).
These modifications were not associated with changes in long-term
potentiation (LTP). LTP was induced in 6 of 9 hippocampal slices in
controls, in 8 of 12 slices in caffeine-exposed, and in 8 of 8 slices in
KW6002-exposed adult offspring (Fig. 5F). The increase in the slope of
the field excitatorypostsynapticpotential (that is, LTP)wasnot significant-
ly different (P = 0.74) between controls (47%), caffeine-exposed (37%),
andKW6002-exposed (51%) adult offspring (Fig. 5F). The stimulus inten-
sity used to evoke field potentials was similar in the three groups, suggest-
ing that the decrease in sEPSC frequency (Fig. 5, B and D) reflects a
hypoactivity of presynaptic glutamatergic networks rather than their loss.
Caffeine-exposed rodent offspring display cognitive
deficits as adults
Given that the reorganization of hippocampal circuitsmaybe associated
with deficits in spatialmemory (46), we assessed hippocampus-dependent
memory in treated and control adult offspring using an object dis-
placement and substitution task. Animals exposed to caffeine during
development showed a lower preference for the displaced object com-
pared to control animals, indicating a deficit in spatial, hippocampus-
dependent memory (P < 0.05, nonparametric t test) (Fig. 6A). Their
performance was also decreased on the nonspatialmemory task, as they
spent similar times exploring the familiar andnewobject (P< 0.05, non-
parametric t test) (Fig. 6B).
Locomotor activity was not altered in caffeine-exposed adult off-
spring (Fig. 6C). However, caffeine-exposed adult offspring displayed
impairment in the novel object recognition test (Fig. 6D) and two-trial
reference memory test in the Y maze (Fig. 6E), in keeping with the re-
sults obtained in rats exposed to caffeine during the embryonic period
only (47). The recognition index for the novel object was decreased by
40% in caffeine-exposed and by 64% in KW6002-exposed adult off-
spring (Fig. 6D; P < 0.05 control versus caffeine, and P < 0.01 vehicleTable 3. Loss of neurons in treated adult offspring. Stereological quanti-
fication of the total number of neurons (identified by NeuN immunoreactivity)
and somatostatin-expressing neurons in the hippocampus is shown for con-
trol, caffeine-exposed, and KW6002-exposed adult mouse offspring. NeuN-
labeled neurons were quantified in the hippocampal regions (stratum oriens,hilus of the dentate gyrus, and stratum radiatum). Somatostatin-expressing in-
terneurons were quantified in the hilus of the dentate gyrus and stratum
oriens, where they weremore abundantly located. Given that vehicle treatment
did not modify any morphological parameter measured at P6, a stereological
quantification was not performed in this group of adult animals.Stratum oriens Dentate gyrus (hilus)ceTranslationalMedicine.orgStratum radiatumNeuN Control Caffeine KW6002 Control Caffeine KW6002 Control7 August 2013CaffeineVol 5 Issue 197KW600219,404 ±
658 (n = 4)11,938 ±
1,506 (n = 4)†15,744 ±
1,113 (n = 3)*17,670 ±
629 (n = 4)10,866 ±
411 (n = 4)†13,776 ±
1,815 (n = 3)*29,154 ±
1,988 (n = 4)19,152 ±
1,152 (n = 4)†22,064 ±
3,778 (n = 4)*Somatostatin Control Caffeine/KW6002 Control Caffeine/KW600216,817 ±
1,072 (n = 3)12,296 ± 592 (n = 3) * 5,884 ±
140 (n = 3)5,141 ± 368 (n = 3)*P < 0.05, one-way ANOVA. †P < 0.01, one-way ANOVA.Fig. 5. GABAergic and glutamatergic activity in hippocampal CA1 PCs in
adult offspring. (A) The frequency of sIPSCs was increased in caffeine-exposed
adult offspring representing an increase inGABAergic activity. (B) The frequencyof
sEPSCswasdecreased in caffeine-exposedadult offspring representing adecrease
in glutamatergic activity. (C and D) Cumulative probability distributions of IEIs for
sIPSCs and sEPSCs in caffeine- and KW6002-exposed adult offspring. Histograms
showing the mean IEIs are depicted below. (E) The glutamatergic synaptic input
wasdecreased inPCsof caffeine- andKW6002-exposedanimals (*P<0.05). (F) LTP
is similar in control andcaffeine- andKW6002-exposedadultmouseoffspring. Left:
Timeevolutionof fieldpostsynaptic potential (fPSP) slopes after tetanic stimulation
applied 10min after obtaining stable baseline. Right: Averaged fPSP slopes before
(gray trace) and 30min after (black trace) tetanic stimulation. *P<0.05, **P < 0.01.197ra104 8





























 versus KW6002). In the modified Y-maze test, all treated animals spent
less time exploring the novel arm during the test trial. The exploration
time decreased from 41 to 36% in caffeine-exposed and from 43 to 37%
inKW6002-exposed adult offspring (Fig. 6E;P< 0.05). Altered perform-
ances in these tasks were not related to increased anxiety because there
was no difference between control, vehicle-treated, caffeine-treated, and
KW6002-treated mice in the time spent in the open arm in the elevated
plus maze (Fig. 6F). These data demonstrate that early life exposure to
caffeine (or KW6002) may lead to altered memory function.DISCUSSION
The results presented here suggest that maternal caffeine consumption
by mouse dams during gestation and lactation has effects on neuronal
development and adult behavior of their offspring. This developmental
effect of caffeine may involve the blockade of A2ARs because caffeine-
induced modifications could be reproduced with a selective A2AR an-
tagonist, although we cannot rule out contributions of the other targetswww.Scienof caffeine, for example, A1 receptors, as shown during parturition (48).
Caffeine treatment did not have a major influence on food and water
intake or on the day/night rhythm of female mice. However, we cannot
fully exclude that treatment-associated physiological or behavioral
changes in dams might have influenced fetal and/or neonatal develop-
ment, for example, through changes in placental perfusion (49). During
the dark, that is, active phase, female caffeine-treated mice showed
increased activity. However, dams and pups were always found in the
nest, suggesting that increased maternal activity did not impair mater-
nal care for pups. The fact that we were able to reproduce our data in
A2AR-KO pups suggests that the impact of perinatal caffeine exposure
on brain developmentmay be linked to antagonismofA2ARby caffeine.
It has been reported that A2AR-KO adult mice display enhanced
workingmemory (50) but not referencememory (51). This finding does
not contradict our results as we stopped the transient interference of
A2ARs after weaning by withdrawing caffeine from the drinking water,
whereas A2ARs are absent throughout life in the A2AR-KO animals.
Thus, our results suggest a new role for A2ARs in the control of hippo-
campal development. However, we cannot fully rule out that theFig. 6. Caffeine exposure during early life leads to memory deficits in
adult offspring. (A) Caffeine-exposed adult offspring (6 months of age, n =
166 ± 12, n = 9; caffeine: 156 ± 10, n = 8, P = 0.588; vehicle: 131 ± 9, n = 10;
KW6002: 147 ± 8, n = 7, P = 0.227). (D and E) In contrast to their respective5) displayed a deficit in hippocampus-dependent spatial memory on the
object displacement task compared to control (n = 7) (A, control, nondisplaced:
−5.46 ± 2.96, displaced: 2.85 ± 3.22, *P < 0.05; caffeine, nondisplaced:
0.36 ± 0.72, displaced: 2.61 ± 2.36, P = 0.286). (B) Caffeine-exposed adult
offspring (6 months of age) also displayed a deficit on the hippocampal-
dependent nonspatial object substitution task compared to control (con-
trol, n = 7, familiar: −6.02 ± 4.01, novel: 11.51 ± 4.20, *P < 0.05; caffeine, n =
5, familiar: 3.55 ± 3.87, novel: 8.32 ± 3.31, P = 0.090). (C to E) Behavior anal-
ysis of control, caffeine-exposed, vehicle-exposed, and KW6002-exposed adult
GIN mouse offspring (at 3 months of age). (C) Locomotion (number of cross-
ings) of animals exposed to caffeine or KW6002, analyzed during the first
session in the open-field arena, was similar to respective controls (control:controls, both caffeine- and KW6002-exposed adult offspring displayed
impaired performance on memory tasks in the object recognition test (D,
control: 0.48 ± 0.04, n = 9, caffeine: 0.29 ± 0.06, n = 8, *P < 0.05, vehicle: 0.39 ±
0.003, n = 10, KW6002: 0.14 ± 0.08, n = 7, **P < 0.01) and by spending less
time exploring the novel arm in the Y maze (E, control: 41 ± 1%, n = 8, caf-
feine: 36 ± 2%, n = 10, *P < 0.05; vehicle: 43 ± 2%, n = 10, KW6002: 37 ± 2%,
n = 7, *P < 0.05). (F) All treated and untreated adult offspring spent a similar
amount of time in the open arm of the elevated plus maze, indicating no
change in anxiety (control: 37 ± 7%, n = 9, caffeine: 29 ± 5%, n = 10, P =
0.423; vehicle: 28 ± 5%, n = 10, KW6002: 26 ± 3%, n = 7, P = 0.817). *P <
0.05, **P < 0.01, one-way ANOVA followed by a Tukey test, comparing
treated with control mice.ceTranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 9





























 caffeine-inducedmaternal hyperactivity andweight loss of the pupsmight
be a potentially confounding factor. In keeping with our observations,
maternal caffeine intake during pregnancy in humans is associated with
lower birth weight but no change in gestational length (52). In humans,
lower birth weight correlates with enhanced seizure susceptibility (53)
and cognitive deficits (54).
The delayed migration of GABA neurons induced by caffeine expo-
surewas associatedwith a general increase in neuronal network activity,
although causality between both observations remains to be established.
These alterations share some similarities with those found in animals
exposed to drugs of abuse during developmental periods (6). After
weaning, animals were not exposed to caffeine any longer, but the early
effects of caffeine on neuronmigration and integration ultimately led to
long-term sequelae in hippocampal circuits. The disruption of develop-
mental programs usually leads to long-term alterations in GABAergic
circuits, typified by neuronal loss (including subpopulations of
somatostatin-containing neurons), and cognitive deficits in adult animals
(40, 55–57). The phenotypic traits observed after caffeine exposure show
some similarities to those found in models of neuronal migration dis-
orders (31) andmodels of psychiatric disorders linked toGABAneuron
dysfunction (41). This suggests that interfering with GABA neurons
during development may have adverse consequences.
The mechanisms underlying the changes in glutamatergic and
GABAergic activities in adult caffeine-exposed offspring may involve
an imbalance between excitation and inhibition; a correct balance is im-
portant for the proper functioning of cortical networks (58, 59). Cogni-
tive deficits in certain psychiatric disorders are also associated with
hyperactivity of inhibitory circuits or hypoactivity of glutamatergic cir-
cuits (41). The altered balance between excitation and inhibition found
in adult caffeine-exposed offspring may contribute to the impaired
memory observed on several memory tests.
The challenge with rodentmodels for studying the effects of psycho-
active drugs is whether the results can be extrapolated to humans given
the differences in development and maturation across species. The ex-
pression of A2ARs in migrating neurons in macaques indicates that
A2AR-related pathways can be potentially affected by caffeine in pri-
mates. Note that caffeine citrate is widely used for the treatment of
apnea in premature human neonates up to 33 to 34 weeks of gestation.
No deleterious consequences of this treatment have been identified in
treated premature neonates up to the age of 5 years (60, 61). Given our
findings, it will be important to develop longitudinal clinical studies to
assess short- and long-term consequences in human neonates born to
women who consumed caffeine on a regular basis during pregnancy
and lactation, as well as in neonates treated with caffeine citrate.MATERIALS AND METHODS
Study design
The overall objective of the studywas to determine the effects of caffeine
consumption (caffeine was added to the drinking water) by mouse
dams on the brain development of their offspring.Hippocampal circuits
of male offspring at P6 from treated and untreated dams were assessed
with electrophysiological, morphological, and immunohistochemical
techniques. Seizure susceptibility was also assessed. When the caffeine-
exposed and control offspring reached adulthood, we assessed hippo-
campal circuits and cognitive performance. A specific antagonist of
A2ARs was also used to assess whether the effects of caffeine could bewww.Sciencedue to its antagonizing action on A2ARs. Time-lapse imaging was used
tomeasure the effects of caffeine andA2AR antagonists on themigration
of GABA neurons inmedial ganglionic eminence cell cocultures. Final-
ly, several cognitive functions, including spatial memory, were assessed
in caffeine-exposed adult offspring.
Animals
Caffeine and KW6002 treatments were performed in GIN mice and in
A2ARconstitutive knockout dams.Caffeinewas given to animals dissolved
in tap water at a concentration of 0.3 g/liter. KW6002 (istradefylline) was
prepared and given to animals at a concentration of 2mg/kg per day in a
vehicle solution containing 0.4% methylcellulose and 0.9% NaCl. Both
treatments were started 15 days beforemating and prolonged during all
gestational period up to P15. Caffeine treatment started at gestational
day 0.5 for experiments assessing the activity of females and behavioral
analysis of pups of treated dams.
Electrophysiology
Transverse hippocampal slices frompups and fromadults. IPSCswere
recorded at a holding potential of +10 mV, the reversal potential for
glutamatergic events, and EPSCs were recorded at −60mV, the reversal
potential for GABAergic events (42). For LTP induction protocol, fPSPs
were recorded in the stratum radiatum of CA1 region and evoked upon
tetanic stimulation of the Schaffer collaterals.
Immunohistochemistry
Immunohistochemistry was performed as previously described (30, 62)
with tissue from rat embryos, GIN mouse pups, A2AR-KO pups, and
adultGINmice. Immunohistochemical localizationofA2ARswasperformed
in E13Wistar rats and E75 cynomolgus monkey (Macaca fascicularis).
Stereological quantification
The numbers of neurons labeled for NeuN, GFP, and somatostatin
were estimated with the optical fractionator method, as previously
described (43).
Cell culture of MGE and analysis of migration speed
GFP-expressing MGE explants (E13.5) were cultured on E13.5-
dissociated cortical cells (26) and monitored by time-lapse video mi-
croscopy before and after drug application.
Measurement of caffeine and its metabolites in brain tissue
The tissue of all brain was homogenized and mixed with 30% of per-
chloric acid, and the supernatant obtained after centrifugation was
separated by high-performance liquid chromatography (HPLC).
Behavioral analysis
Locomotor activity was evaluated in an open-field arena by counting
the total number of crossings for 5 min. Spatial memory performance
was evaluated with themodified Y-maze test (63, 64). The object recog-
nition test was performed, and the recognition index was calculated as
previously described (65, 66). Anxiety was evaluated in an elevated plus
maze (67, 68). The object displacement and substitution task tests were
performed in three stages (69).
Seizure induction with flurothyl
The evaluation of spasm-like movements and seizures was based on
(70). Animals were video-monitored.TranslationalMedicine.org 7 August 2013 Vol 5 Issue 197 197ra104 10
R E S EARCH ART I C L EStatistical analysis
One-wayANOVAwas used to compare the number of neurons and the
physiological activity in the hippocampus of control, vehicle-exposed,
caffeine-exposed, and KW6002-exposed pups and adults. Eventually,
a Tukey test was used as a post hoc test. A Student’s t test was used
in the experiments of cell migration and in the object displacement
and substitution task test. The behavioral parameters of female mice
and pups were analyzed with a three-way or two-way mixed ANOVA,
respectively, followed by Newman-Keuls post hoc tests when appropri-
ate. Statistical significance was considered when P < 0.05. Levels of sig-




















Fig. S1. Physiological and behavioral consequences of caffeine treatment.
Fig. S2. Caffeine exposure during pregnancy and the early postnatal period delays the migra-
tion and insertion of GFP-containing neurons in cortical layers and in the hippocampus.
Fig. S3. Caffeine exposure during pregnancy and the early postnatal period delays the migra-
tion and insertion of somatostatin-containing neurons and the maturation of the hippocampal
GABAergic network.
Fig. S4. Decreased numbers of somatostatin-containing neurons in the hippocampus and in
cortical layers of mice lacking A2ARs.
Table S1. Properties of the spontaneous activity (GDPs) in hippocampal slices from P5 to P7
control, caffeine-exposed, vehicle-exposed, and KW6002-exposed mouse pup offspring.
Table S2. Imbalance between excitatory and inhibitory synaptic inputs in PCs from caffeine-
and KW6002-exposed pup offspring during GDPs.
Table S3. Properties of the spontaneous activity recorded in vitro in hippocampal neurons of
P5 to P7 mouse pup offspring.
Table S4. Imbalance between excitatory and inhibitory synaptic inputs in PCs from caffeine-
and KW6002-exposed pup offspring during spontaneous activity outside GDPs.
Table S5. Properties of the spontaneous activity recorded in vitro in hippocampal neurons
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